BridgeBio Pharma, Inc. (BBIO)
73.99
+1.29
(+1.77%)
USD |
NASDAQ |
Dec 11, 13:37
BridgeBio Pharma Market Cap: 14.26B for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 146.01B |
| Alnylam Pharmaceuticals, Inc. | 54.11B |
| Supernus Pharmaceuticals, Inc. | 2.697B |
| Ionis Pharmaceuticals, Inc. | 12.88B |
| Regeneron Pharmaceuticals, Inc. | 77.85B |
Market Cap Related Metrics
| PS Ratio | 39.84 |
| PEG Ratio | -0.2402 |
| Price | 73.99 |
| Earnings Yield | -5.66% |
| PEGY Ratio | -0.2402 |